RT Journal Article
SR Electronic
T1 EMA suspends licence for ingenol mebutate (Picato)
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 51
OP 51
DO 10.1136/dtb.2020.000012
VO 58
IS 4
YR 2020
UL http://dtb.bmj.com/content/58/4/51.abstract
AB Overview of: Medicines and Healthcare products Regulatory Agency. Ingenol mebutate gel (Picato▼): suspension of the licence due to risk of skin malignancy. Drug Safety Update 2020;13(7):1.